Fierce Pharma·· 2026-06-03精选AI 评分62
礼来与勃林格殷格翰拟各削减至少10亿美元德国投资
Lilly, Boehringer to slash at least $1B each from planned investments in Germany - fiercepharma.com
AI 导读
据Fierce Pharma报道,礼来与勃林格殷格翰将各自从原计划的德国投资中削减至少10亿美元。报道未披露削减的具体原因与涉及项目。
来源:Fierce Pharma · news.google.com